Saint-Ghislain, M., Derrien, A., Geoffrois, L., Gastaud, L., Lesimple, T., Negrier, S., Penel, N., Kurtz, J., Le Corre, Y., Dutriaux, C., Gardrat, S., Barnhill, R., Matet, A., Cassoux, N., Houy, A., Ramtohul, T., Servois, V., Mariani, P., Piperno-Neumann, S., Stern, M., & Rodrigues, M. (2022). mBD4 deficiency is predictive of response to immune checkpoint inhibitors in metastatic uveal melanoma patients. European journal of cancer, 173, 105–112. http://access.bl.uk/ark:/81055/vdc_100163066660.0x000029